These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis. Cohen G; Courvoisier N; Cohen JD; Zaltni S; Sany J; Combe B Clin Exp Rheumatol; 2005; 23(6):795-800. PubMed ID: 16396697 [TBL] [Abstract][Full Text] [Related]
23. Tuberculosis under anti-TNF therapy: case series of a center (reporting the experience from the period 2006-2019). Valido A; Dinis JS; Saavedra MJ; Fonseca JE Acta Reumatol Port; 2020; 45(4):281-287. PubMed ID: 33423034 [TBL] [Abstract][Full Text] [Related]
24. Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol. Soare A; Gheorghiu AM; Aramă V; Bumbăcea D; Dobrotă R; Oneaţă R; Pintilie S; Milicescu M; Ancuţa I; Martin A; Sasu M; Ciofu C; Macovei L; Stoica V; Bojincă M; Mihai C Clin Rheumatol; 2018 Sep; 37(9):2391-2397. PubMed ID: 29150737 [TBL] [Abstract][Full Text] [Related]
25. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD; Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464 [TBL] [Abstract][Full Text] [Related]
26. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases]. Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259 [TBL] [Abstract][Full Text] [Related]
27. Infliximab and brucellosis: not the usual suspects, this time. Akgul O; Ozgocmen S Mod Rheumatol; 2011 Jun; 21(3):313-5. PubMed ID: 21243400 [TBL] [Abstract][Full Text] [Related]
28. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Vassallo R; Matteson E; Thomas CF Chest; 2002 Sep; 122(3):1093-6. PubMed ID: 12226061 [TBL] [Abstract][Full Text] [Related]
29. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750 [TBL] [Abstract][Full Text] [Related]
32. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case? De Rosa FG; Shaz D; Campagna AC; Dellaripa PE; Khettry U; Craven DE Infect Control Hosp Epidemiol; 2003 Jul; 24(7):477-82. PubMed ID: 12887234 [TBL] [Abstract][Full Text] [Related]
34. [Disseminated tuberculosis following infliximab therapy for Crohn disease: a case report]. Bouchentouf R; Yasser Z; Aitbenasser MA Rev Pneumol Clin; 2014 Dec; 70(6):366-9. PubMed ID: 25131370 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis. Imaizumi K; Sugishita M; Usui M; Kawabe T; Hashimoto N; Hasegawa Y Intern Med; 2006; 45(10):685-8. PubMed ID: 16778341 [TBL] [Abstract][Full Text] [Related]
36. [Meta analysis of infection risks of anti-TNF-α treatment in rheumatoid arthritis]. Xie X; Chen J; Peng Y; Gao J; Tian J; Ling G; Du J; Mao N; Wu P; Li F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 38(7):722-36. PubMed ID: 23908082 [TBL] [Abstract][Full Text] [Related]
37. Exacerbation of tuberculosis enteritis after treatment with infliximab. Liberopoulos EN; Drosos AA; Elisaf MS Am J Med; 2002 Nov; 113(7):615. PubMed ID: 12459414 [No Abstract] [Full Text] [Related]